Form 4 for MRNA Moderna
Accepted 2023-09-07 00:00:00 ET · period of report 2023-09-05 · accession 0001127602-23-023856 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-09-07 | 2023-09-06 | MRNA | Garay Arpa | Chief Commercial Off | S - Sale+OE | $108.40 | -574 | 3,113 | -16% | -$62.2K |
| D | 2023-09-07 | 2023-09-05 | MRNA | Garay Arpa | Chief Commercial Off | M - OptEx | — | +1,140 | 3,687 | +45% | — |
| D | 2023-09-07 | 2023-09-05 | MRNA | Garay Arpa | Chief Commercial Off | M - OptEx | $0.00 | -1,140 | 12.5K | -8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-06 | S | D | 574 | $108.40 | 3,113 | D | — | — | |
| 2 | Common | Common Stock | 2023-09-05 | M | A | 1,140 | — | 3,687 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. |
| 3 | Derivative | Restricted Stock Units | 2023-09-05 | M | D | 1,140 | $0.00 | 12,546 | D | — · — to — | 1,140 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F3) 25% of the shares subject to this restricted stock unit award vested on June 5, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter. |